The last decade has seen an impressive dissolution of the thin line dividing neurologic and psychiatric disorders. Today, the fields of neuropsychiatry and behavioral neurology are two of the fastest growing and are most vigorously researched specialties in the medical arena. The past year has seen an incredible increase in the elucidation of both the biological and functional underpinnings of numerous neuropsychiatric conditions, including depression, anxiety disorders, aging-associated diseases, and degenerative diseases. With increased access to imaging and analytic techniques, novel on- and off-label treatment options are emerging on a near-monthly basis.

GTC is proud to host our inaugural 2nd Neuropsychiatric Research and Development to be held September 13-14, 2012 inSan Francisco, CA. This conference will update practitioners in psychiatry, neurology, and primary care on the latest in neuropsychiatric theory and practice. Through a series of presentations led by industry leaders from the fields of medical research, academic research, pharmaceutical development, and biotech engineering, we will supply attendees with the latest developments in neuropsychiatric pathologies, epidemiologies, and treatment options. This conference will provide a forum for intimate discourse that can lead to increased benefits for clients and patients suffering from a number of prominent disorders.